Clinical Trial Update: Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia [Phase 3]

View source ↗

Summary

Phase 3 long-term safety study of eszopiclone in children and adolescents with ADHD-associated insomnia has completed, and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Insomnia

Drugs mentioned

• Eszopiclone (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia, Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-07-22